Source: Reuters Ireland-based Jazz Pharmaceuticals Plc will buy U.S.-based Celator Pharmaceuticals Inc in a cash deal valued at about $1.5 billion, to gain access to an investigational product in development for treating acute myeloid leukemia. Jazz Pharmaceuticals will pay $30.25 per share in cash for Celator, a 72.6 percent premium…...

Source: Reuters The Securities and Exchange Commission is concerned about the way Canadian drugmaker Valeant Pharmaceuticals International Inc (VRX.TO) has been disclosing its "non-GAAP" financial measures, regulatory filings showed on Tuesday. The SEC has questioned Valeant's practice of stripping away acquisition-related expenses from its "non-GAAP" or adjusted metrics, given that…...

Source: Former Warner Chilcott executive Carl Reichel’s day in court has come. The former sales chief stands trial beginning today, on charges that he conspired to pay kickbacks to doctors in return for stepped-up prescriptions for Warner drugs. It’s one of the few times a pharmaceutical executive has been arrested,…...

Source: BY AMRUTHA PENUMUDI Pfizer Inc (PFE.N) is buying Anacor Pharmaceuticals Inc (ANAC.O) in a $5.2 billion deal to add an eczema gel to its portfolio, just a month after the U.S. drug major scrapped plans to acquire Allergan Plc (AGN.N). Anacor shares surged more than 55 percent to $99.48…...

Source: Mylan may have failed in its effort to buy OTC specialist Perrigo ($PRGO), but it is trying to quickly move on. Three months after announcing its $7.2 billion deal for Sweden’s Meda, the company says it will spend about $1 billion to get pick up topical skin meds from…...

Source: Bloomberg Bill Baer was the ultimate Washington antitrust insider when he came to the Justice Department in 2013: At law firm Arnold & Porter LLP, he’d counseled the biggest U.S. companies, including deal machine General Electric Co., on getting mergers over the finish line. So when Baer took over…...